REGN Jun 2024 1020.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:27PM EDT. Market open.
| Previous close | 6.40 |
| Open | 10.84 |
| Bid | 7.20 |
| Ask | 9.20 |
| Strike | 1,020.00 |
| Expiry date | 2024-06-14 |
| Day's range | 6.55 - 13.39 |
| Contract range | N/A |
| Volume | |
| Open interest | 20 |
Investor's Business DailyWhy It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.
Investor's Business DailyWhy Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
Regeneron stock joined the 1,000-club this month as enthusiasm grows for its blockbuster drug, Dupixent, in COPD treatment.
ZacksRegeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
The FDA approves label expansion of Regeneron (REGN) and Sanofi's Kevzara for the treatment of polyarticular juvenile idiopathic arthritis.
© 2024 Yahoo. All rights reserved.